Drug information for FUZEON
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; SUBCUTANEOUS
90MG/VIAL
Prescription
(Reference Drug)
ENFUVIRTIDE
enfuvirtide
ROCHE
21481
2011-05-03 Letter
2011-04-29 Label
2010-01-04 Label
2009-12-31 Letter
2008-12-24 Letter
2007-01-25 Letter
2007-01-24 Label
2006-12-28 Label
2006-12-28 Letter
2006-10-02 Label
2006-10-02 Letter
2005-08-16 Letter
2005-08-15 Label
2005-07-08 Letter
2005-07-07 Label
2004-10-18 Label
2004-10-18 Letter
2003-07-23 Review
2003-03-20 Letter
2003-03-18 Label
Drug Adverse Effects information for FUZEON
Role code
Indications
Reaction
# Reports
PS
HIV INFECTION
EXPIRED DRUG ADMINISTERED
2
PS
HIV INFECTION
HYPOKALAEMIA
1
SS
CONSTIPATION
HEPATIC FUNCTION ABNORMAL
1
SS
CONSTIPATION
RASH MACULO-PAPULAR
1
SS
CONSTIPATION
RENAL IMPAIRMENT
1
SS
FUNGAL INFECTION
HEPATIC FUNCTION ABNORMAL
1
SS
FUNGAL INFECTION
RASH MACULO-PAPULAR
1
SS
FUNGAL INFECTION
RENAL IMPAIRMENT
1
SS
PNEUMOCYSTIS JIROVECI PNEUMONIA
HEPATIC FUNCTION ABNORMAL
1
SS
PNEUMOCYSTIS JIROVECI PNEUMONIA
RASH MACULO-PAPULAR
1
SS
PNEUMOCYSTIS JIROVECI PNEUMONIA
RENAL IMPAIRMENT
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATIC FUNCTION ABNORMAL
10
SS
PRODUCT USED FOR UNKNOWN INDICATION
RASH MACULO-PAPULAR
10
SS
PRODUCT USED FOR UNKNOWN INDICATION
RENAL IMPAIRMENT
10
SS
VOMITING
HEPATIC FUNCTION ABNORMAL
1
SS
VOMITING
RASH MACULO-PAPULAR
1
SS
VOMITING
RENAL IMPAIRMENT
1
C
ACQUIRED IMMUNODEFICIENCY SYNDROME
MATERNAL DRUGS AFFECTING FOETUS
1
C
ACQUIRED IMMUNODEFICIENCY SYNDROME
SMALL FOR DATES BABY
1
C
HIV INFECTION
SMALL FOR DATES BABY
5
Ads by Google